-
HHS issued a summary about a Jan. 12 discussion between Secretary of Health Xavier Becerra and Canadian Health Minister Mark Holland.
-
Colorado officials say they haven’t been able to stand up a program to import drugs from Canada because of drugmaker opposition — and the Biden administration’s inaction.
-
The FDA had been expected to decide by next week, but a back-and-forth between state and federal officials about details of the proposal means the wait will continue, a court document says.
-
The state has filed another lawsuit alleging that the FDA violated the Freedom of Information Act by not properly responding to a request for records about Florida’s attempt to get approval for its proposal.
-
The FDA has long blocked the importation of cheap medicine, agreeing with pharmaceutical manufacturers that it opens the door to opioids. The agency’s own data shows that rarely happens.
-
The Biden administration denies the state's allegations that it is "protecting the interests of pharmaceutical companies" or that it has not properly complied with a public records request.
-
The Trump’ administration approved a rule in 2020 to help clear the way, but groups including the Pharmaceutical Research & Manufacturers of America launched a legal challenge that remains unresolved.
-
In a court filing, the administration says it has no timeline on whether it will allow states to import drugs from Canada, an effort approved under President Donald Trump as a strategy to control costs.
-
Gov. Ron DeSantis said importing prescription drugs through a Canadian wholesaler could save Floridians between $80 million and $150 million a year.
-
On Thursday, Gov. Ron DeSantis included $15 million in his proposed 2021-22 budget for an importation program. That would come on top of $10 million the Legislature already directed toward the plan.